Marvell Technology enters the week of May 6 with analysts scrambling to catch up to a stock that has moved far faster than anyone expected.
The numbers tell the story plainly. MRVL has gained 57% in a single month, closing at $168.75 on May 5 — and the Street's mean price target, last aggregated at $120.88, now sits well below the current price. That's not a valuation ceiling; it's a lag indicator showing just how aggressively the stock has re-rated. The most significant recent action came from UBS on May 4, where Timothy Arcuri maintained a Buy but lifted his target from $120 to $195 — a move that puts MRVL at a meaningful premium to even the most optimistic cluster of updated targets. Barclays upgraded to Overweight from Equal-Weight in mid-April, raising its target to $150 from $105. Oppenheimer followed with a target lift to $170 shortly after. The direction of travel is overwhelmingly bullish: virtually every firm that has published over the past three weeks has raised numbers, not cut them. One holdout — Cantor Fitzgerald, maintaining Neutral with a $120 target — effectively marks the floor of Street skepticism.
The bull case centres on Marvell's data centre franchise. Sequential growth of roughly 9% in that segment reflects durable hyperscaler demand. More notable is the company's forward guidance on its Interconnect business, where management is projecting more than 50% year-over-year growth in FY27 — a figure well ahead of prior expectations. The bear case is thinner but real: gross margin is expected to compress modestly on a sequential basis, and any slowdown in cloud capex cycles could bite. At a trailing P/E of 38.5x and a price-to-book of 8.7x — the latter up nearly 3 turns in the past 30 days — investors are paying a full price for the growth story. The EV/EBITDA of 32.4x has held relatively stable, suggesting the multiple expansion is being driven by earnings re-rating rather than pure sentiment. The next earnings event lands on May 27, which keeps the clock ticking on whether the operating numbers can validate the current price.
Short positioning offers no meaningful counter-narrative here. SI % of free float sits at 3.5% — up about 5% on the week but still down roughly 5% over the past month. The borrow market is the loosest it has been in months: availability is extremely wide, cost-to-borrow is just 0.30% APR (down sharply from the week prior), and the overall availability picture points to an unleveraged short base with no squeeze dynamics whatsoever. The ORTEX short score of 32 — sitting near the low end of the range tracked over recent weeks — confirms there is no meaningful bearish conviction in the lending market. Shorts that were more active in early April, when short shares outstanding briefly spiked above 33 million, have largely pulled back. The borrow market is quiet.
Options positioning tells a mildly more cautious story. The put/call ratio at 1.25 is running above its 20-day average of 1.19, though the z-score of just over 1.0 puts this well within normal territory. The 52-week high on PCR is 1.39, so current levels are elevated but not at the extreme defensive readings seen earlier in the quarter. This looks less like active hedging and more like the natural accumulation of put open interest against a stock that has rallied 57% in a month — investors protecting gains rather than betting on a reversal. Peer semiconductors have had a strong week too: CRDO gained 16.7% on the week, PENG surged 29.6%, and CEVA climbed 35.7% — suggesting the whole group is being re-priced higher on AI and data centre demand, not just MRVL.
On the institutional side, FMR (Fidelity) added over 6 million shares in Q1, holding nearly 14% of the company — the largest single block in the register. BlackRock added 3.4 million shares as recently as April 30. Insiders, however, have been sellers: the President/COO sold $1.6 million of stock on May 1, and the division president sold nearly $8.7 million in April, though these followed routine award grants and carry low significance scores. The 90-day net insider position is positive in share terms but driven by equity awards rather than open-market purchases — not a signal that reads particularly clearly in either direction.
What to watch next is straightforward: the May 27 earnings release will be the first real test of whether the data centre growth story and the Interconnect revenue ramp are tracking toward those aggressive FY27 numbers — and whether gross margins hold closer to expectations than the bears fear.
See the live data behind this article on ORTEX.
Open MRVL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
